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With ongoing demographic transition, epidemiological transition has been emerged as 
a growing concern in India. The share of non-communicable disease in total disease 
burden has increased from 31% in 1990 to 45% in 2010. This paper seeks to explore the 
health scenario of India in the wake of the growing pace of non-communicable diseases 
such as diabetes and hypertension among Indian population using data from health and 
morbidity survey of the National Sample Survey Organisation (2004) and notifies about 
the resource needed to tackle this growing health risk. Given the share of private players 
(70%) in Indian health system, results indicate a higher private expenditure, mostly out-
of-pocket expense, on account of non-communicable diseases. A timely look into the 
matter may tackle a more dreadful situation in near future.
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BacKgrOUnD
Through the early and mid-phase of India’s epidemiological transition, the age pattern of morbid-
ity was overwhelmed with infectious diseases (1). In the recent two decades, the prevalence of 
non-communicable diseases has escalated immensely in India (2). India’s swift progress through 
demographic and epidemiological transition has resulted into a bigger challenge of dual burden 
of communicable and non-communicable diseases (3, 4). With the share of older cohorts increas-
ing relative to that of younger cohorts, infectious and nutritional disorders are being replaced by 
chronic, degenerative, and mental illnesses as the leading causes of morbidity and mortality (5, 6). 
The resulting concern is not just epidemiological but also economic. Non-communicable diseases, 
which could cause long-standing disabilities, have direct economic consequences at households and 
community level, both through the expenses on health care, which divert other expenditure, and also 
on levels of income through reduced labor productivity (7, 8).
Expenditure on health is highly lopsided across the globe, where the developed countries 
spend the most on health per person (9). The Organisation for Economic Co-operation and 
Development (OECD) countries accounted for less than 20% of the world’s population but 
were responsible for almost 90% of the world’s health spending (10). Health expenditure, both 
in terms of percentage of gross domestic product (GDP) spent on health and per capita health 
expenditure, is much higher in the developed countries than developing countries. Unlike in 
economic history of Colonial Age, in recent decades, global share of health spending is undergoing 
gradual but constant change in favor of developing Third World nations (11). Such inevitable 
and deep changes are led by top BRICS1 emerging markets (12). In contrast, the ratio of public 
to private health expenditure is extremely low in India. Further, all the private expenditure in 
1 BRICS refers to the association of five major emerging national economies namely Brazil, Russia, India, China, and South Africa.
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India (as in some other countries) almost exclusively represent 
household’s out-of-pocket health expenses. According to World 
Health Organization (WHO) (13), private share on total health-
care spending in India is as high as 70%, only next to some 
poor African countries. In India, 86% of all private expenditure 
and 72% of total expenditure are out-of-pocket. These high 
out-of-pocket spending on health often takes a higher toll on the 
poor than the rich (14). Poor people in India spend about 15% 
of their monthly household income for medical treatment (15).
South Asian countries are going through a rapid demographic 
transition, which is often accompanied by epidemiological 
transition. In this phase, while communicable diseases are still 
pandemic, non-communicable diseases, such as cardiovascular 
disease, diabetes, respiratory diseases, and cancer, are picking 
pace. Ghaffar et  al. (16) pointed out the growing risk of these 
diseases among South Asian population. The non-communicable 
disease in this region has some special feature in addition to 
those commonly available in the developing countries. The 
metabolic syndrome is very common among urban Indians (17, 
18). The high prevalence of glucose intolerance and the distinc-
tive dyslipidaemic pattern of reduced concentrations of high 
density lipoprotein (HDL) cholesterol and high concentrations 
of triglycerides characterize the metabolic profile, and abdominal 
obesity characterizes the phenotype of the urban adult in India. 
Impaired maternal and fetal nutrition, resulting into low birth 
weight poses a greater risk of cardiovascular disease in South 
Asia. While use of tobacco products increases the risk of cancer 
in the region, indoor air pollution mostly due to burning wood 
fuel contributes to chronic obstructive airway disease (16). Barik 
et  al. (19), in their very recent article, has argued that richer 
Indian adults are at greater risk of developing non-communicable 
diseases such as diabetes, heart disease, and high blood pressure 
than their poorer counterparts. The report of the Global Burden 
of Disease reported that the share of non-communicable disease 
on the disease burden has increased from 31% in 1990 to 45% in 
2010 (20).
Following the demographic transition, developed western 
countries have witnessed an epidemiological transition where 
the share of non-communicable diseases increased in the total 
disease burden. The non-communicable diseases require a very 
different health set up than which is required for communicable 
diseases. In the present paper, we have tried to project the future 
health scenario of India in the wake of demographic transition 
and associated health transition. We have estimated the likely sce-
nario of share of communicable and non-communicable diseases 
among Indians and required economic resource for treatment of 
these maladies. Various countries have developed their National 
Health Accounts (NHA) estimates to plan their health budget 
according to the nature of diseases. India does not have such a 
comprehensive NHA estimate. This present study may throw 
some light to plan health budget according to the need of the 
hour and also for future.
DaTa
We have used the Morbidity and Health care Survey (2004) 60th 
round, carried out by the National Sample Survey Organization 
(NSSO) under the Ministry of Statistics and Programme 
Implementation, Government of India as the main data source 
for the analysis. The survey was canvassed between January to 
June, 2004 across the whole of the Indian Union except (i) Leh 
(Ladakh) and Kargil districts of Jammu and Kashmir, (ii) interior 
villages of Nagaland situated beyond 5 km of the bus route, and 
(iii) villages in Andaman and Nicobar Islands which remain 
inaccessible throughout the year. It covered 73,868 households 
of which 47,302 were from rural areas and 26,566 from urban 
areas. Prevalence of various morbidities and utilization of health-
care services from public and private sources, together with the 
expenditure incurred by the households in this process, have been 
collected through this survey. The survey collected information 
if a person was ailing during the last 15 days prior to the date of 
survey. The individual sample size was 383,338; of which 195,712 
were males and 187,626 females.
The data collected can be summarized in three categories:
•	 The first category comprises the inpatient health care 
received by the household members as hospitalized cases 
during last 365  days. The expenses incurred during the 
reference period for treatment (as an inpatient of a hospital) 
of such ailments and details of the health-care finance have 
been recorded here.
•	 Irrespective of the hospitalization status, the second category 
documents all such ailments for which the patients were 
treated during the 15 days prior to the survey.
•	 The third category includes all ailments suffered during 
15 days prior to the date of survey for which no medical treat-
ment received.
MeThODOlOgY
The classification of communicable and non-communicable 
diseases followed the classification adopted by WHO in Global 
Burden of Disease Studies, 2004 (Table  A1 in Appendix). The 
prevalence of any ailment or morbidity has been defined as the 
number of persons ailing within the reference period per 1,000 
persons exposed to the risk of the ailment from the same group 
of population.
The expected change in the share of each category of mor-
bidities has been estimated up to year 2051. The main assump-
tion behind this projection was that the prevalence rate of each 
morbidity category would remain unchanged among all the age 
groups over time. This is a very strong assumption, but we did 
not have a dataset which allows us to examine disease progression 
in Indian context. However, this demographic projection would 
help us to foresee the future of Indian epidemiology in the course 
of demographic transition, the process already started. Utilization 
of hospitalization services over the 15-day reference period was 
multiplied by 24.33 (i.e., 365/15) to obtain an annualized coun-
terpart of hospitalizations (after netting out any hospitalizations 
reported in the 15-day reference period).
The yearly cost of treatment for communicable and non-
communicable diseases has been estimated based on per unit 
cost of treatment for inpatient and outpatient, derived from 
the NSSO unit-level data. Age-specific hospital days have been 
FigUre 1 | age-specific prevalence of communicable, non-communicable, and other types of diseases in india, 2004. Source: authors’ own calculation 
from NSSO 60th round unit-level data.
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estimated for each disease type. The average cost of treatment per 
stay as an inpatient and average duration of stay were estimated 
for each disease type to obtain per day average cost of treatment 
as inpatients, and multiplying it with the estimated hospital 
days provides the annual cost of treatment as an inpatient. The 
annual out-of-pocket expenditure as outpatient has also been 
estimated following the similar procedure, where out-of-pocket 
expenditure implies to the expenditure a household bears after 
deducting the reimbursement from various health-care financing 
sources. We reached the annual cost of treatment as an outpatient 
by multiplying the average cost of treatment with total number 
of outpatient visit. Age-specific inpatient and outpatient visit has 
been assumed to capture the effect of the increasing prevalence of 
non-communicable diseases beyond age 30 years.
Household level out-of-pocket expenses are the major source 
of health-care finance in India. Since the presence of health 
insurance in India is yet to feel, the rest of the health expenditure 
are met by the government via its provision of free or subsidized 
public facilities (21). Thus, we will focus primarily on only these 
two sources of health-care financing, referring to other funding 
sources when appropriate. Public subsidies for health have been 
estimated as the difference between total expenditure incurred on 
private facilities compared to public facilities. The entire analysis 
has been carried out using appropriate sample weight available in 
the dataset. SPSS 18 PASW software was used to analyze the data.
resUlTs
age-specific Prevalence of 
communicable and non-communicable 
Diseases in india, 2004
In 2004, the prevalence of the communicable and non-commu-
nicable diseases reported in the morbidity and health survey was 
32 and 48, respectively, per 1,000 Indian population (Figure 1). 
We see a dominance of communicable diseases in the very early 
stages of life, but with the advancement of the age, the prevalence 
of non-communicable disease rises manifold. Though the preva-
lence of non-communicable diseases rises continuously after 
age 30 years, it becomes dominant mainly beyond age 45 years 
and increases gradually with the increase in age. The prevalence 
of either communicable or non-communicable disease is low-
est among the population of 15–29  years age group. With the 
increase in the age, the prevalence of both communicable and 
non-communicable disease increases, but the latter increased at 
a much faster rate. The prevalence of communicable diseases has 
been recorded as 56 and 62 among the old (65+ years) and oldest 
old (80+ years) people, respectively. In contrast, the prevalence 
of non-communicable diseases for the same age group was much 
higher, counting 288 and 340 respectively.
non-communicable Diseases Will Take 
even a higher share among indian 
Population by 2051
In India, about half of the disease burden was shared by non-com-
municable diseases (46.4%), such as diabetes, high blood pressure, 
cardiac condition, whereas the share of communicable diseases, 
such as tuberculosis and malaria, was 34% (Figure 2). The share 
of communicable diseases was likely to reduce to one-fourth by 
2051. At the same time, the share of non-communicable diseases 
has been projected to increase to 57.4%. A minimal decline will be 
observed in the share of other health condition during the same 
period. This shift in share will be observed mainly due to the shift 
in age distribution of population toward elderly hood.
health spending on non-communicable 
Diseases and government subsidies
There were 75 million hospitalization cases during January to 
June, 2004, out of which 35 million were in government health 
FigUre 2 | Projected share of communicable, non-communicable 
and other types of diseases among total population 2006–2051. 
Source: authors’ own calculation from NSS 60th round unit-level data.
TaBle 1 | Total number of person hospitalized, average duration of stay as inpatient, and total number of hospital days in government and private 
sector, 2004.
hospitalization – government (in million)
average duration of  
stay – government (days) hospital days – government (million)
0–34 35–44 45–64 65+ Total 0–34 35–44 45–64 65+ Total 0–34 35–44 45–64 65+ Total
CD 7.81 2.39 2.98 0.85 14.19 7.39 9.49 11.26 9.6 8.81 57.7 22.7 33.6 8.2 122.2
NCD 3.84 1.79 3.57 1.90 11.69 10.83 15.34 12.75 10.29 11.96 41.5 27.4 45.6 19.5 134.0
Others 5.00 1.80 1.95 0.59 9.44 10.19 14.62 12.65 12.08 11.64 51.0 26.2 24.7 7.2 109.1
Total 16.65 5.98 8.51 3.34 35.32 9.18 13.08 12.24 10.4 10.72 152.8 78.2 104.1 34.8 369.9
hospitalization – private (in million) average duration of stay – private (days) hospital days – private (million)
CD 7.30 1.91 2.53 0.89 12.79 5.97 6.4 7.73 8.34 6.65 43.6 12.2 19.5 7.4 82.8
NCD 5.15 2.50 4.68 2.35 15.43 8.39 8.76 9.05 8.5 8.68 43.2 21.9 42.4 20.0 127.5
Others 6.00 2.10 2.52 0.91 11.72 8.7 9.92 9.92 10.15 9.33 52.2 20.9 25.0 9.3 107.3
Total 18.46 6.52 9.72 4.16 39.94 7.55 8.36 8.91 8.83 8.21 139.4 54.5 86.6 36.7 317.2
Source: authors’ own calculation from NSS 60th round unit-level data.
TaBle 2 | average cost per stay and average cost of hospitalization per day by source of providers, 2004.
average cost per stay as inpatient (inr) Per day average cost of hospitalization (inr)
0–34 35–44 45–64 65+ Total 0–34 35–44 45–64 65+ Total
CD 2,815 3,079 3,369 3,346 3,034 381 324 299 349 344
NCD 5,643 8,522 8,030 5,918 6,876 521 556 630 575 575
Others 4,463 5,701 5,748 5,321 5,014 438 390 454 440 431
Govt. 4,071 5,658 5,963 5,120 4,935 444 433 487 492 460
CD 5,763 10,522 9,877 12,347 8,015 965 1,644 1,278 1,480 1,205
NCD 10,262 16,263 17,799 14,244 14,377 1,223 1,857 1,967 1,676 1,656
Others 10,080 12,278 13,733 14,249 11,718 1,159 1,238 1,384 1,404 1,256
Pvt. 8,454 13,202 14,613 13,835 11,552 1,120 1,579 1,640 1,567 1,407
Source: authors’ own calculation from NSS 60th round unit-level data.
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facilities and 40 million in private facilities (Table 1). We did not 
find any remarkable difference in hospitalization due to com-
municable and non-communicable diseases. Hospitalization in 
government facilities for communicable diseases was relatively 
higher than for non-communicable diseases. People usually rush 
to private facilities for hospitalization in case of non-communi-
cable diseases. Beyond age 45 years, the volume of hospitalized 
persons due to non-communicable diseases was higher than 
communicable diseases in both government and private facili-
ties. Again, the average duration of stay as an inpatient was much 
higher for non-communicable diseases than for communicable 
diseases (Table  2). Once hospitalized, the average duration of 
stay in government facilities was higher than private facilities. 
The number of hospital days was higher for non-communicable 
diseases than communicable diseases in both government as well 
as private facilities.
The average cost of hospitalization per stay at private facilities 
(INR 11,552) was much higher than in public facilities (INR 
4,935) for any type of illnesses (Table 2). For non-communicable 
diseases, average cost per stay as an inpatient was as high as INR 
14,377 in private compared to INR 6,876 in government. The 
average cost of treatment either as inpatient or outpatient was 
higher in private than in public. Each inpatient day accounted 
more than three times higher cost in private facilities than in 
public. In government facilities, average per day cost of hospi-
talization for communicable diseases was high among the youth 
(age less than 34  years) and the elderly (65  years and above). 
People of the prime working age (35–44  years) usually spent 
more on private facilities when suffered from communicable 
diseases.
There were nearly 1,740 million outpatient visits during 
2004, out of which 380 million were in government and 1,360 
TaBle 3 | Particulars of outpatient care visits, per visit total expenditure, and out-of-pocket expenditure by type of diseases and source of providers, 2004.
Total number of visit for outpatient  
care (in millions) Per visit cost (inr) for outpatient care Per visit OOP cost (inr) for outpatient care
0–34 35–44 45–64 65+ Total 0–34 35–44 45–64 65+ Total 0–34 35–44 45–64 65+ Total
CD 88.7 13.5 29.0 9.4 140.7 189.2 207.2 222.4 236.7 201.0 184.7 205.4 221.2 236.7 197.7
NCD 40.7 22.3 52.6 49.2 164.1 223.3 187.0 238.7 208.6 219.2 221.5 183.9 235.3 202.8 215.6
Others 38.9 12.8 15.5 11.8 78.7 217.7 406.0 166.1 242.5 241.4 182.0 404.1 164.8 241.7 223.1
Govt. 168.3 48.6 97.1 70.4 383.6 204.0 250.2 222.3 218.0 217.1 193.0 247.8 219.9 213.8 210.6
CD 381.7 57.5 79.1 32.9 550.9 248.8 274.1 401.8 375.6 281.3 248.5 273.2 399.4 372.6 280.5
NCD 145.3 63.6 180.0 153.2 540.2 321.3 352.6 374.7 339.5 348.2 318.8 351.7 369.1 339.0 345.4
Others 142.6 38.7 54.6 32.2 267.8 329.7 330.8 314.8 260.1 318.8 323.4 330.8 311.7 259.4 314.7
Pvt. 669.6 159.8 313.7 218.2 1,358.8 281.8 319.1 371.1 333.2 315.3 279.7 318.4 366.7 332.3 313.0
Source: authors’ own calculation from NSS 60th round unit-level data.
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million in private. Outpatient visit was higher in private facili-
ties than government in all the age groups. Outpatient visit 
due to communicable diseases was highest in 0- to 34-year 
age group in both government and private facilities but 
resurged with age. Outpatient visit for non-communicable 
diseases increased with age in both types of health facilities 
(Table 3). Similar to inpatient care, per visit cost of outpatient 
treatment was much higher in private facilities than public 
facilities. Although the cost of treatment in private was higher 
than that of public, people rushed to private facilities when 
in need. This signifies the shortfall of public health systems 
either in reach or in belief or both in Indian context. Cost 
of treatment for outpatient care was also higher for non-
communicable diseases than communicable diseases in both 
types of facilities.
Higher cost of treatment among the elderly age group 
compared to younger age groups has a clearer implication on 
future health-care cost since the proportion of elderly has been 
projected to increase substantially with a rising burden of non-
communicable diseases. Per visit out-of-pocket cost of treatment 
was similar to the total cost of treatment – indicates the failure 
of health insurance as a potential tool for effective health-care 
finance. This high out-of-pocket health spending leads to the 
catastrophic level of spending for health care and pushes house-
holds to poverty trap (22–24). Barman et al. (24) pointed out that 
outpatient care was more impoverishing than inpatient care in 
urban and rural areas alike.
Government subsidies per inpatient and outpatient day were 
estimated INR 795 (Table  4) and INR 103 (Table  5), respec-
tively. Subsidies per inpatient day for all types of diseases were 
higher than outpatient days. In 2004, Government provided a 
total subsidy for health care of INR 335 billion, out of which 
INR 294 billion (Table  4) was for inpatient treatment and 
INR 41 billion (Table 5) for outpatient treatment in 2004. The 
majority share of the total government subsidy was utilized 
for treatment of non-communicable diseases.
TaBle 4 | government subsidy per inpatient day and total subsidy for inpatient care by type of disease, 2004.
government subsidy per inpatient day (inr) Total subsidy in government (billion inr)
0–34 35–44 45–64 65+ Total 0–34 35–44 45–64 65+ Total
CD 548 1,154 770 896 737 31.6 26.2 25.8 7.3 90.0
NCD 655 1,072 1,011 937 892 27.2 29.4 46.0 18.3 119.5
Others 644 768 771 699 706 32.8 20.2 19.0 5.0 77.0
Total 621 985 896 872 795 94.9 77.0 93.3 30.3 294.1
Source: authors’ own calculation from NSS 60th round unit-level data.
TaBle 5 | government subsidy per outpatient visit and total subsidy for outpatient care by type of disease, 2004.
government subsidy per outpatient day (inr) Outpatient visit in government (million)
Total subsidy for outpatient care in 
government (inr billion)
0–34 35–44 45–64 65 +  Total 0–34 35–44 45–64 65+ Total 0–34 35–44 45–64 65+ Total
CD 63.86 67.75 178.16 135.87 82.74 88.7 13.49 28.97 9.44 140.74 5.66 0.91 5.16 1.28 13.02
NCD 97.29 167.8 133.78 136.22 129.81 40.7 22.33 52.64 49.18 164.12 3.96 3.75 7.04 6.7 21.45
Others 141.4 −73.31 146.86 17.68 91.59 38.9 12.78 15.45 11.75 78.72 5.5 −0.94 2.27 0.21 7.04
Total 86.75 70.63 146.84 118.51 102.45 168.3 48.6 97.06 70.38 383.58 14.6 3.43 14.25 8.34 40.63
Source: National Sample Survey 60 Round, 25.0 sub-round, 2004.
TaBle 6 | Projected annual health-care cost (inr crores) in government 
and private facilities for communicable and non-communicable diseases 
in india.
2006 2026 2051
communicable diseases
Government 4,352 5,877 7,364
Private 26,243 34,634 42,222
non-communicable diseases
Government 8,424 13,294 20,722
Private 45,734 72,535 114,413
Source: authors’ own calculation from NSSO 60th round unit-level data.
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health-care spending on communicable 
and non-communicable Diseases as a 
share of gross Domestic Product
In 2004, 87% of the total health-care spending in India (approxi-
mately INR 100,000 crores) was out-of-pocket spending. India 
spent 3.35% of the GDP, and out-of-pocket spending on health 
accounted 2.94% of it. Half of the out-of-pocket spending on 
health care was on account of the treatment of non-commu-
nicable diseases and 30% was due to communicable diseases 
during 2004.
health-care expenditure on 
communicable Diseases and  
non-communicable Diseases in india: 
a Futuristic Vision
The health-care expenditure on the communicable diseases 
was expected to grow rather slowly than non-communicable 
diseases. Health-care expenditure on communicable diseases in 
government facilities may rise by about 1.7 times by 2051 than 
its corresponding figure in 2006 (Table 6), whereas expenditure 
on non-communicable diseases in government facilities may 
increase in a much faster rate by 2.5 times within the same time 
frame. In the private health facilities, health-care expenditure on 
the communicable diseases are expected to increase from INR 
26,243 crores to INR 42,222 crores and on non-communicable 
diseases from INR 45,735 crores to 114,413 crores during the 
same duration. The rise in health-care expenditure due to 
communicable diseases is relatively higher in the first part of 
the projection period (2006–26) compared to the second part 
(2026–2051).
DiscUssiOn
The study provides some insights into the upcoming health 
requirements in Indian health system. The age profile of the 
morbidity indicates a rising risk of non-communicable diseases 
as the population ages through demographic transition (2, 16, 
25, 26). In spite of a higher cost of treatment, people prefer 
to visit private facilities than the public. In India, the private 
facilities are vast and diverse – ranging from a person from local 
medical shop to a super specialty hospital catering to medical 
tourists from abroad (27). These facilities are available even in 
small remote places and offers services as per the convenience 
of people. The cost of treatment in these private facilities also 
varies to a great extent. People frequently prefer to go to a 
nearby private facility for short term diseases, which requires 
outpatient visit. Choice among various private health prac-
titioners arises when the disease is more severe and requires 
long-term care.
Though government provides subsidized services for public 
health facilities, people utilize these facilities mainly for inpa-
tient care. The lower level government facilities such as the sub-
centers and the primary health centers are not well equipped to 
serve for severe illnesses. The higher level and specialized gov-
ernment health facilities are often concentrated in urban places, 
and travel to these places requires higher level resources and 
often associated with wage loss (27). India, in the past decade, 
has introduced the Rashtriya Swasthya Bima Yojana, a health 
insurance scheme to cover the inpatient care expenses of the 
poor. It has also invested on the National Rural Health Mission 
in 2005, which provides budget support to expand and improve 
free primary care in public clinics. While these initiatives ensure 
government’s continued effort to improve health-care services 
and protect the poor from health related expenses, these barely 
promise on the step toward combating non-communicable 
disease risks.
cOnclUsiOn
The non-communicable diseases require attention at a very early 
stage and once developed, medication continues throughout 
lifetime. Neglecting these diseases incapacitates a person and 
may be even life threatening. Ghaffar et  al. (16) attributed 
the environmental factors as the major determinants of these 
health conditions, whereas they noted sedentary life style, 
extreme poverty, and inadequate health system as the obsta-
cle to tackle the challenge of non-communicable diseases in 
South Asia.
If India wishes to reap the demographic dividend out of its 
favorable age-structural transition, it needs to focus on the health 
of the youth. Creating an enabling atmosphere for the youth to 
lead a healthy life style, create awareness about the ill health 
effects of smoking and drinking, regular health check-ups, and 
good dietary intake, are the some among the possible ways to 
avoid health risks from non-communicable diseases. In a nut-
shell, investing on youth health may result into a higher return 
in future.
liMiTaTiOns
We acknowledge the possible various limitation of the study. The 
main limitation stands as the prevalence of morbidity is based 
on the reported ailments, which is subject to the knowledge 
and awareness of a particular morbidity and may differ from 
estimate-based clinical data. The study produces the shift in 
disease share on the basis of pure demographic profile, which 
certainly sets a basic level of alarm to Indian health system, 
7Barik and Arokiasamy Rising Health Expenditure on NCD
Frontiers in Public Health | www.frontiersin.org November 2016 | Volume 4 | Article 268
reFerences
1. Murray CJ, Lopez AD. Alternative projections of mortality and disability 
by cause 1990–2020: Global Burden of Disease Study. Lancet (1997) 
349(9064):1498–504. doi:10.1016/S0140-6736(96)07492-2 
2. Reddy KS, Shah B, Varghese C, Ramadoss A. Responding to the threat of 
chronic diseases in India. Lancet (2005) 366(9498):1744–9. doi:10.1016/
S0140-6736(05)67343-6 
3. Jakovljevic MB, Milovanovic O. Growing burden of non-communicable dis-
eases in the emerging health markets: the case of BRICS. Front Public Health 
(2015) 3:65. doi:10.3389/fpubh.2015.00065 
4. Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular 
diseases part I: general considerations, the epidemiologic transition, risk 
factors, and impact of urbanization. Circulation (2001) 104(22):2746–53. 
doi:10.1161/hc4601.099487 
5. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and 
regional burden of disease and risk factors, 2001: systematic analysis of 
population health data. Lancet (2006) 367(9524):1747–57. doi:10.1016/
S0140-6736(06)68770-9 
6. McKeown RE. The epidemiologic transition: changing patterns of mortality 
and population dynamics. Am J Lifestyle Med (2009) 3(1 Suppl):19S–26S. 
doi:10.1177/1559827609335350 
7. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and 
costs of chronic diseases in low-income and middle-income countries. Lancet 
(2007) 370(9603):1929–38. doi:10.1016/S0140-6736(07)61696-1 
8. United Nations, Department of Economic and Social Affairs, Population 
Division. World Population Prospects: The 2015 Revision, Key Findings and 
Advance Tables. New York: United Nations (2015).
9. Getzen TE, Poullier J-P. International health spending forecasts: con-
cepts and evaluation. Soc Sci Med (1992) 34(9):1057–68. doi:10.1016/ 
0277-9536(92)90136-E 
10. World Health Organization. The World Health Report 2003: Shaping the 
Future. Geneva: World Health Organization (2003).
11. Jakovljevic M, Getzen TE. Growth of global health spending share in low 
and middle income countries. Front Pharmacol (2016) 7:21. doi:10.3389/
fphar.2016.00021 
12. Jakovljevic MM. Comparison of historical medical spending patterns among 
the BRICS and G7. J Med Econ (2016) 19(1):70–6. doi:10.3111/13696998.20
15.1093493 
13. World Health Organization. World Health Statistics 2014. Geneva: World 
Health Organization (2014).
14. Jakovljevic MB. BRIC’s growing share of global health spending and 
their diverging pathways. Front Public Health (2015) 3:135. doi:10.3389/
fpubh.2015.00135 
15. Barik D, Desai S. Determinants of private healthcare utilisation and expen-
diture patterns in India. In: Ghosh SBAS, editor. India Infrastructure Report 
2013|14 The Road to Universal Health Coverage. New Delhi, India: IDFC Ltd. 
(2014). p. 52–64.
16. Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in 
South Asia. BMJ (2004) 328(7443):807–10. doi:10.1136/bmj.328.7443.807 
17. Gupta R, Gupta V, Sarna M, Bhatnagar S, Thanvi J, Sharma V, et al. Prevalence 
of coronary heart disease and risk factors in an urban Indian population: 
Jaipur Heart Watch-2. Indian Heart J (2001) 54(1):59–66. 
18. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic 
syndrome in urban Asian Indian adults – a population study using modified 
ATP III criteria. Diabetes Res Clin Pract (2003) 60(3):199–204. doi:10.1016/
S0168-8227(03)00060-3 
19. Barik D, Desai S, Vanneman R. Adult mortality in India: the health-wealth 
nexus. Population Association of America Annual Conference. Washington, 
DC, USA (2016).
20. Global Burden of Disease Study 2013 Collaborators, Charlson F, Erskine 
H, Ferrari A, Gouda H, Knibbs L, et al. Global, regional, and national inci-
dence, prevalence, and years lived with disability for 301 acute and chronic 
diseases and injuries in 188 countries, 1990-2013: a systematic analysis for 
the Global Burden of Disease Study 2013. Lancet (2015) 386(9995):743–800. 
doi:10.1016/S0140-6736(15)60692-4 
21. Mahal A. Policy implications of the distribution of public subsidies on 
health and education: the case of Karnataka, India. Comp Educ Rev (2005) 
49(4):552–74. doi:10.1086/454376 
22. Ghosh S. Catastrophic payments and impoverishment due to out-of-pocket 
health spending. Econ Polit Wkly (2011) XLVI:8. 
23. Pal R. Measuring incidence of catastrophic out-of-pocket health expenditure: 
with application to India. Int J Health Care Finance Econ (2012) 12(1):63–85. 
doi:10.1007/s10754-012-9103-4 
24. Barman P, Ahuja R, Bhandari L. The impoverishing effect of healthcare 
payments in India: new methodology and findings. Econ Polit Wkly (2010) 
XLV(16):7. 
25. Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens 
(2004) 18(2):73–8. doi:10.1038/sj.jhh.1001633 
26. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 
diabetes: Indian scenario. Indian J Med Res (2007) 125(3):217. 
27. Desai SB, Dubey A, Joshi BL, Sen M, Shariff A, Vanneman R. Human 
Development in India: Challenges for a Society in Transition. New Delhi: 
Oxford University Press (2010).
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2016 Barik and Arokiasamy. This is an open-access article distributed 
under the terms of the Creative Commons Attribution License (CC BY). The use, 
distribution or reproduction in other forums is permitted, provided the original 
author(s) or licensor are credited and that the original publication in this journal 
is cited, in accordance with accepted academic practice. No use, distribution or 
reproduction is permitted which does not comply with these terms.
but inadequate in long run. A longitudinal study with clinical 
investigation will help a more detailed projection. However, we 
have tried to pinpoint the short fall of the Indian health system 
to tackle the future health problem, which will come along with 
the ongoing demographic transition.
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aPPenDiX
TaBle a1 | classification of communicable and non-communicable 
diseases.
Communicable 
disease
Diarrhea/dysentery, gastritis/gastric or peptic ulcer, worm 
infestation, amebiasis, hepatitis/jaundice, tuberculosis, 
diseases of kidney/urinary system, conjunctivitis, sexually 
transmitted diseases, malaria, eruptive, mumps, diphtheria, 
whooping cough, fever of unknown origin, tetanus, and 
filariasis/elephantiasis
Non-
communicable 
disease
Heart disease, hypertension, respiratory including ear/
nose/throat ailments, bronchial asthma, disorders of joints 
and bones, prostatic disorders, gynecological disorders, 
neurological disorders, psychiatric disorders, glaucoma, 
cataract, diseases of skin, goiter, diabetes mellitus, anemia, 
locomotor, visual including blindness (excluding cataract), 
speech, hearing, and diseases of mouth/teeth/gum, cancer, 
and other tumors
Others Under-nutrition, accidents/injuries/burns/fractures/
poisoning, other diagnosed ailments, and other 
undiagnosed ailments
